Page last updated: 2024-12-06

lorazepam glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID62966
CHEBI ID185278
MeSH IDM0098420

Synonyms (14)

Synonym
lorazepam glucuronide
(2s,3s,4s,5r,6s)-6-[[7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
32781-79-6
(2s,3s,4s,5r,6s)-6-{[7-chloro-5-(2-chlorophenyl)-2-hydroxy-3h-1,4-benzodiazepin-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
CHEBI:185278
unii-p0g8i56129
beta-d-glucopyranosiduronic acid, 7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepin-3-yl
p0g8i56129 ,
.beta.-d-glucopyranosiduronic acid, 7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepin-3-yl
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2h-1,4-benzodiazepin-2-one glucuronide
(2s,3s,4s,5r,6s)-6-((7-chloro-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic acid
Q27285962
7-chloro-5-(2-chlorophenyl)-2-hydroxy-3h-1,4-benzodiazepin-3-yl hexopyranosiduronic acid
DTXSID90954442

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Lorazepam kinetics after subchronic dosing were linear."( Effect of renal impairment and hemodialysis on lorazepam kinetics.
Chiang, ST; Koepke, HH; Morrison, G; Walker, BR, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glucosiduronic acidAny substance produced by linking glucuronic acid to another substance via a glycosidic bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (28.57)18.7374
1990's2 (14.29)18.2507
2000's7 (50.00)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.20 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (21.43%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (78.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]